Search research articles
Contact Us
Filters
Showing results (1-10 of 4) with videos related to
Page
of 1
Sort By:
European Journal of Clinical Investigation
|
April 26, 2003
Increased intestinal permeability as a cause of fluctuating postprandial blood glucose levels in Type 1 diabetic patients
T Damci, I Nuhoglu, G Devranoglu, et al.
Bratislavske Lekarske Listy
|
December 25, 2010
An evaluation of the tuberculin skin test for anti TNF alpha prophylaxis in patients with ankylosing spondylitis and rheumatoid arthritis
M Karkucak, E Capkin, S Ozsu, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association
|
April 9, 2014
Comparison of effects of gliclazide, metformin and pioglitazone monotherapies on glycemic control and cardiovascular risk factors in patients with newly diagnosed uncontrolled type 2 diabetes mellitus
C Erem, H M Ozbas, I Nuhoglu, et al.
Journal of Endocrinological Investigation
|
May 5, 2009
Blood coagulation and fibrinolysis in patients with Cushing's syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels
C Erem, I Nuhoglu, M Yilmaz, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 4) with videos related to
Sort By:
Page
of 1
European Journal of Clinical Investigation
|
April 26, 2003
Increased intestinal permeability as a cause of fluctuating postprandial blood glucose levels in Type 1 diabetic patients
T Damci, I Nuhoglu, G Devranoglu, et al.
Bratislavske Lekarske Listy
|
December 25, 2010
An evaluation of the tuberculin skin test for anti TNF alpha prophylaxis in patients with ankylosing spondylitis and rheumatoid arthritis
M Karkucak, E Capkin, S Ozsu, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association
|
April 9, 2014
Comparison of effects of gliclazide, metformin and pioglitazone monotherapies on glycemic control and cardiovascular risk factors in patients with newly diagnosed uncontrolled type 2 diabetes mellitus
C Erem, H M Ozbas, I Nuhoglu, et al.
Journal of Endocrinological Investigation
|
May 5, 2009
Blood coagulation and fibrinolysis in patients with Cushing's syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels
C Erem, I Nuhoglu, M Yilmaz, et al.
Page
of 1